Products

See leaflet See Risk Management Plan

Roxifer®
deferasirox

Indications

  • Treatment of Chronic Iron Overload secondary to transfusions.
  • Treatment of Chronic Iron Overload in non-transfusion-dependent thalassemic syndromes.

Presentations

  • 125 mg x 28 tablets for oral suspension
  • 250 mg x 28 tablets for oral suspension
  • 500 mg x 28 tablets for oral suspension